Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Apr 2021 07:00 AM
RNS
Ovarian cancer study patient enrolment completed
19 Apr 2021 02:05 PM
RNS
Second Price Monitoring Extn
19 Apr 2021 02:00 PM
RNS
Price Monitoring Extension
19 Apr 2021 11:05 AM
RNS
Second Price Monitoring Extn
19 Apr 2021 11:00 AM
RNS
Price Monitoring Extension
16 Apr 2021 07:00 AM
RNS
First large-scale pharma services contract secured
15 Apr 2021 04:10 PM
RNS
Notice of Preliminary Results and Webcast
12 Apr 2021 07:00 AM
RNS
ANGLE's Parsortix system showcased at AACR 2021
30 Mar 2021 07:00 AM
RNS
Global launch of clinical services laboratories
04 Mar 2021 07:00 AM
RNS
Update on submission for FDA clearance
18 Feb 2021 07:00 AM
RNS
Parsortix-harvested CTCs uncover novel biomarker
08 Feb 2021 07:00 AM
RNS
Parsortix: Dynamic assessment of patient response
29 Jan 2021 07:00 AM
RNS
Parsortix demonstrates high capture rate of CTCs
26 Jan 2021 01:00 PM
RNS
Holding(s) in Company
20 Jan 2021 07:00 AM
RNS
Research confirms high performance of Parsortix
12 Jan 2021 07:00 AM
RNS
Change of Auditor
05 Jan 2021 07:00 AM
RNS
Issue of Equity
09 Dec 2020 07:00 AM
RNS
Parsortix can capture single cancer cell in sample
20 Nov 2020 04:18 PM
RNS
Holding(s) in Company
18 Nov 2020 04:51 PM
RNS
Holding(s) in Company
13 Nov 2020 10:46 AM
RNS
Result of General Meeting
03 Nov 2020 02:54 PM
RNS
Director/PDMR Shareholding
29 Oct 2020 07:00 AM
RNS
Interim Results
27 Oct 2020 06:28 PM
RNS
Result of Placing & Notice of General Meeting
27 Oct 2020 07:00 AM
RNS
Accelerated bookbuild to raise up to £20m
20 Oct 2020 07:00 AM
RNS
Submission accepted by FDA for substantive review
28 Sep 2020 07:00 AM
RNS
Issue of LTIP Options and Share Options
28 Sep 2020 07:00 AM
RNS
ANGLE announces completion of FDA submission
23 Sep 2020 07:00 AM
RNS
Potential treatment strategy to limit metastasis
11 Sep 2020 03:35 PM
RNS
Holding(s) in Company
11 Sep 2020 03:30 PM
RNS
Holding(s) in Company
02 Sep 2020 01:49 PM
RNS
Notification of Interim Results and Webcast
02 Sep 2020 10:00 AM
RNS
Holding(s) in Company
27 Aug 2020 03:13 PM
RNS
Result of 2020 Annual General Meeting
18 Aug 2020 09:30 AM
RNS
Holding(s) in Company
14 Aug 2020 07:00 AM
RNS
Parsortix use to assess response to immunotherapy
06 Aug 2020 12:20 PM
RNS
Holding(s) in Company
05 Aug 2020 07:00 AM
RNS
Notice of AGM and Posting of Annual Report
20 Jul 2020 07:00 AM
RNS
Study: Parsortix use in metastatic breast cancer
08 Jul 2020 05:35 PM
RNS
Holding(s) in Company
08 Jul 2020 05:30 PM
RNS
Holding(s) in Company
08 Jul 2020 05:30 PM
RNS
Holding(s) in Company
25 Jun 2020 07:00 AM
RNS
Preliminary Results
22 Jun 2020 07:00 AM
RNS
Blood donations recommenced for FDA studies
29 May 2020 07:00 AM
RNS
Notice of Results
12 May 2020 07:00 AM
RNS
CTC potential as biomarker in MET inhibitor trials
04 May 2020 07:00 AM
RNS
Leading cancer centre publishes Parsortix workflow
28 Apr 2020 07:00 AM
RNS
Business Update
17 Apr 2020 07:00 AM
RNS
Parsortix performance in head and neck cancer
31 Mar 2020 07:00 AM
RNS
COVID-19 BUSINESS IMPACT UPDATE

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, Angle listed on LSE in 2004 under the ticker AGL.

UK 100

Latest directors dealings